NCT00040066UnknownPhase 1
Development of Human Laboratory Study Model of Cocaine Relapse Prevention
National Institute on Drug Abuse (NIDA)2 sites in 1 country32 target enrollmentStarted: May 1, 2002Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Enrollment
- 32
- Locations
- 2
- Primary Endpoint
- Cocaine related high
Study Overview
Brief Summary
The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.
Detailed Description
The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.
Study Design
- Study Type
- Interventional
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Cocaine dependent, non treatment seeking individuals
Exclusion Criteria
- •Please contact site directly for details.
Outcomes
Primary Outcomes
Cocaine related high
Cocaine craving
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Non-Treatment Study of Factors Affecting Cocaine Drug ChoiceCocaine Abuse or DependenceCocaine Related DisordersNCT00946660Wayne State University16
Completed
Phase 2
Pharmacological Modulation of Cocaine Effects - 1Cocaine-Related DisordersNCT00000201National Institute on Drug Abuse (NIDA)
Completed
Phase 1
Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent VolunteersCocaine DependenceNCT00656357Biotie Therapies Inc.20
Completed
Phase 2
Early Phase II Trials for Cocaine Medication Development - 1Cocaine-Related DisordersSubstance-Related DisordersNCT00000317New York State Psychiatric Institute31
Completed
Phase 2
IV Cocaine Abuse: A Laboratory Model - 4Cocaine-Related DisordersNCT00000215National Institute on Drug Abuse (NIDA)